Dietary Peanuts and Nutrition-Related Outcomes
Dietary Peanut Intake and Nutrition-Related Outcomes in Individuals Using GLP-1 Receptor Agonists: A Randomized Controlled Trial
Ian J. Neeland, MD
64 participants
Apr 20, 2026
INTERVENTIONAL
Conditions
Summary
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
Eligibility
Inclusion Criteria1
- Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months
Exclusion Criteria4
- No use or contraindication to use of a GLP-1 RA
- Known allergy to nuts
- Pregnant or breastfeeding
- Incarcerated
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will eat 2 ounces, or about 53 grams, of dry-roasted, lightly salted peanuts each day along with their regular diet
DEXA scans will be used to measure body fat
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07244458